Canada vs Europe: Proportion of the target population who received the final dose of
Canada
86.0%
in 2024
Europe
40.0%
in 2024
Canada rank
18th
Europe rank
21st
Proportion of the target population who received the final dose of over time
- Canada
- Europe
How they compare
Canada currently reports 86.0% against 40.0% in Europe, a difference of 46.0%.
That makes Canada's figure about 2.1 times Europe's.
Across all 12 years both countries report, Canada has been ahead every year.
Canada ranks 18th and Europe ranks 21st of 107 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 32.0% | 46.6% | Canada |
| 2020s | 86.4% | 36.8% | 49.6% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Canada or Europe?
- Canada, at 86.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Canada and Europe?
- 46.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Europe?
- 12 years are reported by both, from 2013 to 2024.
- How do Canada and Europe rank globally for proportion of the target population who received the final dose of?
- Canada ranks 18th and Europe ranks 21st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.